化学资讯学的全球市场:现状分析与预测(2021年～2027年)

全球化学资讯学的市场规模在预测期间(2021年～2027年)中预计将以约13％的年复合成长率成长。

研发项目投资的增加、个体化医疗意识的提高和慢性病的增加正在推动化学信息学市场的增长。此外，行业併购和加大对行业的投资预计将对市场产生积极影响。

本报告提供全球化学资讯学市场的相关调查，提供市场洞察，市场趋势，竞争模式，企业概要等全面性资讯。

目录

第1章 市场简介

• 市场定义
• 限制
• 相关利益者
• 报告所使用的货币

第2章 调查方法或假设

• 化学资讯学市场调查流程
• 化学资讯学市场调查手法
• 预测方法
• 受访者简介
• 化学资讯学市场调查的主要目的

第3章 市场摘要

第4章 摘要整理

第5章 全球化学资讯学市场上COVID-19影响

第6章 全球化学资讯学市场收益(2019年～2027年)

第7章 市场洞察:各应用领域

• 药物研发
• 化学分析
• 药物检验

第8章 市场洞察:各终端用户

• 化学及製药产业
• 研究及学术机构
• 其他

第9章 市场洞察:各地区

• 北美的化学资讯学市场
  • 美国
  • 加拿大
  • 其他的北美
• 欧洲的化学资讯学市场
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 其他的欧洲
• 亚太地区的化学资讯学市场
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 其他的亚太地区
• 其他

第10章 化学资讯学市场动态

• 推动市场要素
• 市场课题
• 影响分析

第11章 化学资讯学市场机会

第12章 化学资讯学市场趋势

第13章 相关法规

第14章 需求与供给面分析

• 需求面分析
• 供给面分析

第15章 价值链分析

第16章 竞争模式

• 波特的五力分析

第17章 公司概要

• Jubilant Biosys
• Molecular Discovery Ltd.
• OpenEye Scientific Software
• Dassault Systemes
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• BioSolveIT GmbH
• Schrodinger, LLC
• ChemAxon Ltd.
• Golden Helix, Inc.

第18章 免责声明

The chemoinformatics market is expected to register a CAGR of around 13% over the period of 2021-2027. Cheminformatics is a new area of information technology (IT) focused on the collection, storage, analysis, and manipulation of chemical data. Chemical data includes small molecule formulas, structures, properties, spectra, and biological and industrial activities. Cheminformatics helps define archived data logs and depict three-dimensional (3D) molecular structures, further enabling the search and comparison of compounds with specific properties. As a result, it is widely used in the pharmaceutical industry to discover and develop new biotechnology processes and products. Chemoinformatics is being widely utilized in drug discovery & designing, information handling, screening, molecular modelling, analytical chemistry, Quantitative structure-activity relationship (QSAR), and also in polymers, food science & material science. The applications of this technique are in chemical data collection, representation, analysis, database designing, structure prediction, and building statistical models.

The rise in the investment in research and development (R & D) projects is driving the demand for chemoinformatics to validate potential drug candidates and effectively manage data generated during molecular and atomic reactions. Moreover, the increasing awareness about personalized medicine is driving the market growth. For instance, in 2012, the number of personalized medicine in the U.S was 81 which increased to 286 in 2020.

Furthermore, the increasing prevalence of various chronic diseases significantly boosts the demand for therapeutics which increase the discovery of the new drugs in the market. This rise in drug discovery, increases the industry funding, mergers and acquisition, and investments in the industry is anticipated to positively impact the chemoinformatics market globally. For example, In 2020, Optibrium, a developer of software for drug discovery, announced a collaboration with MSD tradename of Merck & Co., Inc, Kenilworth NJ USA. As part of the collaboration, MSD has adopted Optibrium's StarDrop™ software as a central component of their cheminformatics infrastructure.

Jubilant Biosys, Molecular Discovery Ltd., OpenEye Scientific Software, Dassault Systemes, Agilent Technologies, Bio-Rad Laboratories, Inc., BioSolveIT GmbH, Schrodinger, LLC, ChemAxon Ltd., Golden Helix, Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

"Amongst Applications, the chemical analysis category accounted for the majority share in the market in 2020"

Based on application, the market is classified into drug discovery, chemical analysis, and drug validation. Amongst applications, the chemical analysis category accounted for a significant share in the market. this segment is growing because of the increasing investments in R&D and the relatively low success rate of the potential leads as drug molecules.

"Among End-Users, the chemical and pharmaceutical industry is expected to witness highest CAGR during the forecast period"

Based on end-users, the market is categorized into chemical and pharmaceutical industries, research and academic Institution, and others. Among these, the chemical and pharmaceutical industry is expected to witness the highest CAGR during the forecast period. The growth of this segment is attributed to the increased demand for personalized medicine, and novel drug discoveries and development.

"North America to witness significant growth during the forecast period"

For a better understanding of the market dynamics of the chemoinformatics market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the chemoinformatics market industry in 2020 owing to the strong healthcare infrastructure and growing adoption of chemoinformatics in the region.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

• The report presents a quick review of overall industry performance at one glance.

• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

• The study comprehensively covers the market across different segments.

• Deep dive regional level analysis of the industry.

Customization Options:

Global chemoinformatics market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1.      MARKET INTRODUCTION

• 1.1.   Market Definitions
• 1.2.   Limitation
• 1.3.   Stake Holders
• 1.4.   Currency used in Report

2.      RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1.   Research Process of the Chemoinformatics Market
• 2.2.   Research Methodology of the Chemoinformatics Market
• 2.3.   Forecasting Method
• 2.4.   Respondent Profile
• 2.5.   Main Objective of the Chemoinformatics Market Study

3.      MARKET SYNOPSIS

4.      EXECUTIVE SUMMARY

5.      GLOBAL CHEMOINFORMATICS MARKET COVID-19 IMPACT

6.      GLOBAL CHEMOINFORMATICS MARKET REVENUE, 2019-2027F

7.      MARKET INSIGHTS BY APPLICATION

• 7.1.   Drug Discovery
• 7.2.   Chemical Analysis
• 7.3.   Drug Validation

8.      MARKET INSIGHTS BY END-USERS

• 8.1.   Chemical And Pharmaceutical Industry
• 8.2.   Research And Academic Institution
• 8.3.   Others

9.      MARKET INSIGHTS BY REGION

• 9.1.   North America Chemoinformatics Market
  • 9.1.1.United States
  • 9.1.2.Canada
  • 9.1.3.Rest of North America
• 9.2.   Europe Chemoinformatics Market
  • 9.2.1.Germany
  • 9.2.2.France
  • 9.2.3.United Kingdom
  • 9.2.4.Italy
  • 9.2.5.Spain
  • 9.2.6.Rest of Europe
• 9.3.   Asia Pacific Chemoinformatics Market
  • 9.3.1.China
  • 9.3.2.Japan
  • 9.3.3.India
  • 9.3.4.Australia
  • 9.3.5.Rest of Asia Pacific
• 9.4.   Rest of World Chemoinformatics Market

10.  CHEMOINFORMATICS MARKET DYNAMICS

• 10.1.                  Market Drivers
• 10.2.                  Market Challenges
• 10.3.                  Impact Analysis

11.  CHEMOINFORMATICS MARKET OPPORTUNITIES

12.  CHEMOINFORMATICS MARKET TRENDS

13.  LEGAL & REGULATORY FRAMEWORK

14.  DEMAND AND SUPPLY SIDE ANALYSIS

• 14.1.                  Demand Side Analysis
• 14.2.                  Supply Side Analysis

15.  VALUE CHAIN ANALYSIS

16.  COMPETITIVE SCENARIO

• 16.1.                  Porter's Five Forces Analysis

17.  COMPANY PROFILED

• 17.1.                  Jubilant Biosys
• 17.2.                  Molecular Discovery Ltd.
• 17.3.                  OpenEye Scientific Software
• 17.4.                  Dassault Systemes
• 17.5.                  Agilent Technologies
• 17.6.                  Bio-Rad Laboratories, Inc.
• 17.7.                  BioSolveIT GmbH
• 17.8.                  Schrodinger, LLC
• 17.9.                  ChemAxon Ltd.
• 17.10.               Golden Helix, Inc.

18.  DISCLAIMER